相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions
Jarogniew J. Łuszczki
Pharmacological Reports (2014)
Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
J. Maia et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects
Teresa Nunes et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
Patrick Kwan et al.
EPILEPSIA (2010)
Implications of hormonal and neuroendocrine changes associated with seizures and antiepileptic drugs: A clinical perspective
Alison M. Pack
EPILEPSIA (2010)
Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial
Steve Chung et al.
EPILEPSIA (2010)
When clinical trials make history: Demonstrating efficacy of new antiepileptic drugs as monotherapy
Emilio Perucca
EPILEPSIA (2010)
Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta-analysis
Stefan Beyenburg et al.
EPILEPSIA (2010)
Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures
Christopher M. DeGiorgio
EPILEPSY & BEHAVIOR (2010)
A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures
Christian E. Elger et al.
EPILEPSY RESEARCH (2010)
Key factors in the discovery and development of new antiepileptic drugs
Meir Bialer et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Adjunctive brivaracetam for refractory partial-onset seizures A randomized, controlled trial
J. A. French et al.
NEUROLOGY (2010)
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures
A. Gil-Nagel et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain An 18-week Double-blind Placebo-controlled Trial of Fixed-dose Regimens
James P. Wymer et al.
CLINICAL JOURNAL OF PAIN (2009)
Eslicarbazepine Acetate
Paul L. McCormack et al.
CNS DRUGS (2009)
Lacosamide In Partial-Onset Seizures
Sarah A. Cross et al.
DRUGS (2009)
Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial
Peter Halasz et al.
EPILEPSIA (2009)
Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo-controlled trial
Martin J. Brodie et al.
EPILEPSIA (2009)
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study
Christian Elger et al.
EPILEPSIA (2009)
Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: First European experience
Gerhard Kluger et al.
EPILEPSY & BEHAVIOR (2009)
The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy
Doodipala Samba Reddy
EPILEPSY RESEARCH (2009)
Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)
Meir Bialer et al.
EPILEPSY RESEARCH (2009)
Lacosamide in Painful Diabetic Neuropathy: An 18-Week Double-Blind Placebo-Controlled Trial
Aziz Shaibani et al.
JOURNAL OF PAIN (2009)
Antipsychotic-Like Effect of Retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic Acid Ester], a KCNQ Potassium Channel Opener, via Modulation of Mesolimbic Dopaminergic Neurotransmission
Florence Sotty et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Refinement of the Binding Site and Mode of Action of the Anticonvulsant Retigabine on KCNQ K+ Channels
Wienke Lange et al.
MOLECULAR PHARMACOLOGY (2009)
Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS
C. A. Kushida et al.
NEUROLOGY (2009)
Potassium channels Brief overview and implications in epilepsy
Eduardo E. Benarroch
NEUROLOGY (2009)
Brivaracetam inhibits spreading depression in rat neocortical slices in vitro
Doru Georg Margineanu et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2009)
The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men
Paul Rolan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
A. Matagne et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models
H. Steve White et al.
EPILEPSIA (2008)
Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures
Victor Biton et al.
EPILEPSIA (2008)
Rufinamide: Clinical pharmacokinetics and concentration-response relationships in patients with epilepsy
Emilio Perucca et al.
EPILEPSIA (2008)
Effect of the new antiepileptic drug retigabine in a rodent model of mania
Ditte Dencker et al.
EPILEPSY & BEHAVIOR (2008)
Nervous system KV7 disorders:: breakdown of a subthreshold brake
Snezana Maljevic et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes
B. A. Neubauer et al.
NEUROLOGY (2008)
Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome
T. Glauser et al.
NEUROLOGY (2008)
Retigabine, the specific KCNQ channel opener, blocks ectopic discharges in axotomized sensory fibres
Carolina Roza et al.
PAIN (2008)
Should we care about pregabalin for elderly patients with a history of cardiac dysrhythmia?
M. -A. Laville et al.
REVUE DE MEDECINE INTERNE (2008)
Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment
Luis Almeida et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
The Investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels
Adam C. Errington et al.
MOLECULAR PHARMACOLOGY (2008)
Quantifying the response to antiepileptic drugs
Yitzhak Schiller et al.
NEUROLOGY (2008)
Pharmacokinetics and metabolism of C-14-brivaracetam, a novel SV2A ligand, in healthy subjects
Maria Laura Sargentini-Maier et al.
DRUG METABOLISM AND DISPOSITION (2008)
Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy
Vincent A. Pieribone et al.
EPILEPSIA (2007)
Results of treatment changes in patients with apparently drug-resistant chronic epilepsy
Anna L. Luciano et al.
ANNALS OF NEUROLOGY (2007)
Likelihood of seizure remission in an adult population with refractory epilepsy
Brian C. Callaghan et al.
ANNALS OF NEUROLOGY (2007)
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model
D. G. A. Kasteleijn-Nolst Trenite et al.
NEUROLOGY (2007)
Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures
Elinor Ben-Menachem et al.
EPILEPSIA (2007)
Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs
Deana M. Gazzola et al.
EPILEPSIA (2007)
The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males
Maria Laura Sargentini-Maier et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures
R. J. Porter et al.
NEUROLOGY (2007)
Eslicarbazepine acetate: A double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures
Christian Elger et al.
EPILEPSIA (2007)
Progress report on new antiepileptic drugs: A summary of the Eigth Eflat Conference (EILAT VIII)
Meir Bialer et al.
EPILEPSY RESEARCH (2007)
Eslicarbazepine acetate (BIA 2-093)
Luis Almeida et al.
NEUROTHERAPEUTICS (2007)
Lacosamide: A review of preclinical properties
Bettina K. Beyreuther et al.
CNS DRUG REVIEWS (2007)
Emerging drugs for epilepsy
Patrick Kwan et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
Molecular targets for antiepileptic drug development
Brian S. Meldrum et al.
NEUROTHERAPEUTICS (2007)
Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats
Claudia Brandt et al.
EPILEPSIA (2006)
The effect of the new antiepileptic drug rufinamide on cognitive functions
Albert P. Aldenkamp et al.
EPILEPSIA (2006)
Diverse mechanisms of antiepileptic drugs in the development pipeline
Michael A. Rogawski
EPILEPSY RESEARCH (2006)
Allopregnanolone and ganaxolone increase the firing activity of dorsal raphe nucleus serotonergic neurons in female rats
M Robichaud et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
What is the biological significance of BDNF mRNA targeting in the dendrites? Clues from epilepsy and cortical development
E Tongiorgi et al.
MOLECULAR NEUROBIOLOGY (2006)
Pathways modulating neural KCNQ/M (Kv7) potassium channels
P Delmas et al.
NATURE REVIEWS NEUROSCIENCE (2005)
The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model
GE Duncan et al.
EPILEPSY RESEARCH (2005)
Anxiolytic effects of maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels
MPG Korsgaard et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Molecular determinants of KCNQ (KV7) K+ channel sensitivity to the anticonvulsant retigabine
A Schenzer et al.
JOURNAL OF NEUROSCIENCE (2005)
The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate
TV Wuttke et al.
MOLECULAR PHARMACOLOGY (2005)
Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity
BM Kenda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)
M Bialer et al.
EPILEPSY RESEARCH (2004)
Collapsin response mediator proteins (CRMPs) - Involvement in nervoust system development and adult neurodegenerative disorders
E Charrier et al.
MOLECULAR NEUROBIOLOGY (2003)
Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects
GM Ferron et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects
R Hermann et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain
G Blackburn-Munro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Effects of age and sex on the disposition of retigabine
R Hermann et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine
A Parada et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers
GM Ferron et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels:: Comparison with carbamazepine
MJ Bonifácio et al.
EPILEPSIA (2001)
Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine
D Hainzl et al.
EPILEPSY RESEARCH (2001)
Rufinamide:: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy
S Pålhagen et al.
EPILEPSY RESEARCH (2001)
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
M Bialer et al.
EPILEPSY RESEARCH (2001)
Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse
MA Rogawski et al.
NEUROPHARMACOLOGY (2001)
Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial
JF Kerrigan et al.
EPILEPSY RESEARCH (2000)
Pathophysiology of KCNQ channels: Neonatal epilepsy and progressive deafness
TJ Jentsch et al.
EPILEPSIA (2000)
The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits
C Rundfeldt et al.
NEUROSCIENCE LETTERS (2000)
Assessment of ganaxolone's anticonvulsant activity using a randomized, double-blind, presurgical trial design
K Laxer et al.
EPILEPSIA (2000)
KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy
MA Rogawski
TRENDS IN NEUROSCIENCES (2000)
分享论文
